20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
InMode (NASDAQ:INMD) shares are trading higher after the company reported better-than-expected second-quarter EPS and sales results. The company also issued fiscal year 2020 sales guidance above analyst estimates.
InMode is a provider of minimally-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions are designed to address three energy-based treatment categories including face and body contouring, medical aesthetics and women's health. The technologies offered by the company include BodyTite, Contoura, EmbraceRF, Optimas, and Votiva among others.
InMode shares were trading at $35.23 but have since fallen to $32.57 at time of publication on Wednesday. The stock has a 52-week high of $58.76 and a 52-week low of $13.06.
Related Link:
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!